BDX Becton, Dickinson and Company

BDX Becton, Dickinson and Company

Healthcare · Medical Instruments & Supplies

Market read

Scan convergence 1 scan as of 2026-10-16 1 bull converging

POC $154.67 · VWAP $158.98 · +20.6% vs 12m avg buyer

uptrend vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CEO, EVP sold $799.2K, Aug 14–27

Coverage

1 watchlist

BDX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist BDX belongs to, members best 30-day change first — BDX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings BDX reports in 19 days Nov 5

Last report Aug 6

Reported the quarter ending 2026-06-30: revenue $4.98B, diluted EPS $1.37, net income $377M (SEC filing). Across the print the stock moved +3.6% (close before → first close after).

full note →

Against street estimates

How BDX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 6 · projection Oct 16

Result
Aug 6 3.143.23 GAAP ≠ +2.9%Beat
May 7 2.772.90 GAAP ≠ +4.5%Beat
Feb 9 2.812.91 GAAP ≠ +3.5%Beat
Nov 6 '25 3.913.96+1.1%In line
Aug 7 '25 3.403.68 GAAP ≠ +8.2%Beat
May 1 '25 3.283.35 GAAP ≠ +2.1%Beat
Feb 5 '25 2.993.43 GAAP ≠ +14.7%Beat
Nov 7 '24 3.773.81+1.1%In line